(Q45300954)

11 December 2017

title

Vasomotor hyporeactivity in the anterior cerebral artery during motor activation in Huntington's disease patients (English)

1 reference

11 December 2017

0 references

Deckel AW

1

1 reference

11 December 2017

Duffy JD

series ordinal

2

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

11 December 2017

1 reference

11 December 2017

volume

872

1 reference

11 December 2017

issue

1-2

1 reference

11 December 2017

page(s)

258-261

1 reference

Clinical-pathologic correlation in Huntington's disease: a neuropsychological and computed tomography study

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Nitric oxide synthases: targets for therapeutic strategies in neurological diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Increased CBF velocity during word fluency in Huntington's disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Cerebral blood flow velocity decreases during cognitive stimulation in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Spinal nerve lesion induces upregulation of neuronal nitric oxide synthase in the spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Unified Huntington's disease rating scale: Reliability and consistency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Reduced regional cerebral blood flow in Huntington's disease studied by SPECT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Bright and dark sides of nitric oxide in ischemic brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Single photon emission computed tomography in Huntington's chorea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Paradoxical fate and biological action of peroxynitrite on human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Imaging of cerebral blood flow markers in Huntington's disease using single photon emission computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Evidence of cortical metabolic dysfunction in early Huntington's disease by single-photon-emission computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Huntington disease: Clinical care and evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Technetium-99m HMPAO imaging in patients with basal ganglia disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

No NO prevents parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Neuritic sprouting with aberrant expression of the nitric oxide synthase III gene in neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Nitric oxide in cerebral ischemic neurodegeneration and excitotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

Cerebral blood flow and cognitive testing correlate in Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2800%2902506-3

10.1016/S0006-8993(00)02506-3

7 January 2021

Identifiers

DOI

1 reference

11 December 2017

1 reference